Skip to main content
Top
Published in: Calcified Tissue International 5/2019

01-11-2019 | Diabetes | Original Research

Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study

Authors: Ruizhi Jiajue, Xuan Qi, Yan Jiang, Qiuping Wang, Wenbo Wang, Yu Pei, Xiran Wang, Wei Huang, Xin Zheng, Zhiwei Ning, Ou Wang, Mei Li, Xiaoping Xing, Wei Yu, Ling Xu, Weibo Xia

Published in: Calcified Tissue International | Issue 5/2019

Login to get access

Abstract

Using data from the Peking Vertebral Fracture Study, we conducted a longitudinal cohort study to investigate the association between type 2 diabetes mellitus (T2DM) and the risk of incident fractures, especially of vertebral fractures (VFs), and we also examined the modifying effect of body mass index (BMI) on this association and the effect of bone mineral density (BMD) T-score as a risk factor for incident fractures in T2DM. Chinese postmenopausal women were enrolled (n = 982), among whom 186 had T2DM. Incident VFs were confirmed by lateral radiographs of the thoracolumbar spine (T4–L5), while incident clinical non-VFs were self-reported. BMDs at the lumbar spine (LS) and femoral neck (FN) were measured by dual-energy X-ray absorptiometry. T2DM and non-DM women were at similar risk for VFs (OR 0.74, 95% CI 0.32–1.74), even adjusting for age, BMI, BMD, and previous fractures. Meanwhile, T2DM women had nearly twice the risk for non-VFs (HR 1.95, 95% CI 1.11–3.35) compared with non-DM women. After stratifying by BMI, the risk of VFs remained similar between diabetics and non-diabetics despite their BMI status (p for interaction = 0.470), and the risk of non-VFs was positively associated with T2DM only in women with BMI ≥ 25 kg/m2 (HR 3.59, 95% CI 1.68–7.65) (p for interaction = 0.065). Although LS BMD T-score was similarly and negatively associated with incident VFs both in T2DM (OR 0.34, 95% CI 0.12–0.88) and non-DM women (OR 0.60, 95% CI 0.44–0.82) (p for interaction = 0.430), the FN BMD T-score was not found to be significantly associated with either non-VFs or VFs among T2DM women. Comparing T2DM and non-DM women with similar fracture risks, the mean difference in LS T-score was − 0.36 (95% CI − 1.77 to 1.04) for VF, and difference in FN T-score was 1.61 (95% CI − 0.11 to 3.34) for non-VF. In conclusion, Chinese postmenopausal women with T2DM had a similar risk of incident VFs, but a significantly higher risk of incident non-VF, compared to women without DM. Higher BMI did not modify the effect of T2DM on risk of VFs, but it increased the association between T2DM and risk of non-VFs. LS BMD T-score was similarly and negatively associated with VF risk in T2DM and non-DM women and appear to be useful for clinical evaluation of VF risk.
Literature
1.
go back to reference Meyer HE, Tverdal A, Falch JA (1993) Risk factors for hip fracture in middle-aged Norwegian women and men. Am J Epidemiol 137(11):1203–1211CrossRefPubMed Meyer HE, Tverdal A, Falch JA (1993) Risk factors for hip fracture in middle-aged Norwegian women and men. Am J Epidemiol 137(11):1203–1211CrossRefPubMed
2.
go back to reference Forsén L, Meyer HE, Midthjell K, Edna TH (1999) Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey. Diabetologia 42(8):920–925CrossRefPubMed Forsén L, Meyer HE, Midthjell K, Edna TH (1999) Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey. Diabetologia 42(8):920–925CrossRefPubMed
3.
go back to reference Ivers RQ, Cumming RG, Mitchell P, Peduto AJ (2001) Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care 24(7):1198–1203CrossRefPubMed Ivers RQ, Cumming RG, Mitchell P, Peduto AJ (2001) Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care 24(7):1198–1203CrossRefPubMed
4.
go back to reference Luetters CM, Keegan TH, Sidney S et al (2004) Risk factors for foot fracture among individuals aged 45 years and older. Osteoporos Int 15(12):957–963CrossRefPubMed Luetters CM, Keegan TH, Sidney S et al (2004) Risk factors for foot fracture among individuals aged 45 years and older. Osteoporos Int 15(12):957–963CrossRefPubMed
5.
go back to reference Bonds DE, Larson JC, Schwartz AV et al (2006) Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study. J Clin Endocrinol Metab 91(9):3404–3410CrossRefPubMed Bonds DE, Larson JC, Schwartz AV et al (2006) Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study. J Clin Endocrinol Metab 91(9):3404–3410CrossRefPubMed
6.
go back to reference Jiajue R, Jiang Y, Wang O et al (2014) Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus. Osteoporos Int 25(8):1999–2005CrossRefPubMed Jiajue R, Jiang Y, Wang O et al (2014) Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus. Osteoporos Int 25(8):1999–2005CrossRefPubMed
7.
go back to reference Liao CC, Lin CS, Shih CC et al (2014) Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care 37(8):2246–2252CrossRefPubMed Liao CC, Lin CS, Shih CC et al (2014) Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care 37(8):2246–2252CrossRefPubMed
8.
go back to reference Koh WP, Wang R, Ang LW, Heng D, Yuan JM, Yu MC (2010) Diabetes and risk of hip fracture in the Singapore Chinese Health Study. Diabetes Care 33(8):1766–1770CrossRefPubMedPubMedCentral Koh WP, Wang R, Ang LW, Heng D, Yuan JM, Yu MC (2010) Diabetes and risk of hip fracture in the Singapore Chinese Health Study. Diabetes Care 33(8):1766–1770CrossRefPubMedPubMedCentral
9.
go back to reference Holmberg AH, Johnell O, Nilsson PM, Nilsson J, Berglund G, Akesson K (2006) Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 17(7):1065–1077CrossRefPubMed Holmberg AH, Johnell O, Nilsson PM, Nilsson J, Berglund G, Akesson K (2006) Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 17(7):1065–1077CrossRefPubMed
10.
go back to reference Janghorbani M, Feskanich D, Willett WC, Hu F (2006) Prospective study of diabetes and risk of hip fracture: the Nurses’ Health Study. Diabetes Care 29(7):1573–1578CrossRefPubMed Janghorbani M, Feskanich D, Willett WC, Hu F (2006) Prospective study of diabetes and risk of hip fracture: the Nurses’ Health Study. Diabetes Care 29(7):1573–1578CrossRefPubMed
11.
go back to reference Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T (2008) Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcif Tissue Int 83(5):324–331CrossRefPubMed Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T (2008) Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcif Tissue Int 83(5):324–331CrossRefPubMed
12.
go back to reference Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T (2009) Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res 24(4):702–709CrossRefPubMed Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T (2009) Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res 24(4):702–709CrossRefPubMed
13.
go back to reference Schwartz AV, Sellmeyer DE, Ensrud KE et al (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86(1):32–38CrossRefPubMed Schwartz AV, Sellmeyer DE, Ensrud KE et al (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86(1):32–38CrossRefPubMed
15.
go back to reference Tseng VL, Yu F, Lum F, Coleman AL (2012) Risk of fractures following cataract surgery in Medicare beneficiaries. JAMA 308(5):493–501CrossRefPubMed Tseng VL, Yu F, Lum F, Coleman AL (2012) Risk of fractures following cataract surgery in Medicare beneficiaries. JAMA 308(5):493–501CrossRefPubMed
16.
go back to reference Holm JP, Jensen T, Hyldstrup L, Jensen JB (2018) Fracture risk in women with type II diabetes. Results from a historical cohort with fracture follow-up. Endocrine 60(1):151–158CrossRefPubMed Holm JP, Jensen T, Hyldstrup L, Jensen JB (2018) Fracture risk in women with type II diabetes. Results from a historical cohort with fracture follow-up. Endocrine 60(1):151–158CrossRefPubMed
17.
go back to reference Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes–a meta-analysis. Osteoporos Int 18(4):427–444CrossRefPubMed Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes–a meta-analysis. Osteoporos Int 18(4):427–444CrossRefPubMed
18.
go back to reference Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359CrossRefPubMed Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359CrossRefPubMed
19.
go back to reference Torréns JI, Skurnick J, Davidow AL et al (2004) Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women’s Health Across the Nation (SWAN). Diabetes Care 27(2):354–361CrossRef Torréns JI, Skurnick J, Davidow AL et al (2004) Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women’s Health Across the Nation (SWAN). Diabetes Care 27(2):354–361CrossRef
20.
go back to reference Gu D, Reynolds K, Wu X et al (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365(9468):1398–1405CrossRefPubMed Gu D, Reynolds K, Wu X et al (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365(9468):1398–1405CrossRefPubMed
21.
go back to reference Ensrud KE, Blackwell TL, Fink HA et al (2016) What proportion of incident radiographic vertebral fractures in older men is clinically diagnosed and vice versa: a prospective study. J Bone Miner Res 31(8):1500–1503CrossRefPubMedPubMedCentral Ensrud KE, Blackwell TL, Fink HA et al (2016) What proportion of incident radiographic vertebral fractures in older men is clinically diagnosed and vice versa: a prospective study. J Bone Miner Res 31(8):1500–1503CrossRefPubMedPubMedCentral
22.
go back to reference Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 7(2):221–227CrossRefPubMed Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 7(2):221–227CrossRefPubMed
23.
go back to reference Hanley DA, Brown JP, Tenenhouse A et al (2003) Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res 18(4):784–790CrossRefPubMed Hanley DA, Brown JP, Tenenhouse A et al (2003) Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res 18(4):784–790CrossRefPubMed
24.
go back to reference Napoli N, Schwartz AV, Schafer AL, Vittinghoff E, Cawthon PM, Parimi N, Orwoll E, Strotmeyer ES, Hoffman AR, Barrett-Connor E, Black DM (2018) Vertebral fracture risk in diabetic elderly men: the MrOS study. J Bone Miner Res 33:63–69CrossRefPubMed Napoli N, Schwartz AV, Schafer AL, Vittinghoff E, Cawthon PM, Parimi N, Orwoll E, Strotmeyer ES, Hoffman AR, Barrett-Connor E, Black DM (2018) Vertebral fracture risk in diabetic elderly men: the MrOS study. J Bone Miner Res 33:63–69CrossRefPubMed
25.
go back to reference Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T (2012) Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 97:1277–1284CrossRefPubMed Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T (2012) Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 97:1277–1284CrossRefPubMed
26.
go back to reference Tuominen JT, Impivaara O, Puukka P, Rönnemaa T (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22:1196–1200CrossRefPubMed Tuominen JT, Impivaara O, Puukka P, Rönnemaa T (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22:1196–1200CrossRefPubMed
27.
go back to reference Sahin G, Bağis S, Cimen OB, Ozişik S, Güler H, Erdoğan C (2001) Lumbar and femoral bone mineral density in type 2 Turkish diabetic patients. Acta Medica (Hradec Kralove) 44:141–143CrossRef Sahin G, Bağis S, Cimen OB, Ozişik S, Güler H, Erdoğan C (2001) Lumbar and femoral bone mineral density in type 2 Turkish diabetic patients. Acta Medica (Hradec Kralove) 44:141–143CrossRef
29.
go back to reference Ferrari SL, Abrahamsen BD, Napoli N et al (2018) Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29(12):2585–2596CrossRefPubMedPubMedCentral Ferrari SL, Abrahamsen BD, Napoli N et al (2018) Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29(12):2585–2596CrossRefPubMedPubMedCentral
30.
go back to reference Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL (2017) Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol 13(4):208–219CrossRefPubMed Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL (2017) Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol 13(4):208–219CrossRefPubMed
31.
go back to reference Starup-Linde J, Eriksen SA, Lykkeboe S, Handberg A, Vestergaard P (2014) Biochemical markers of bone turnover in diabetes patients—a meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos Int 25:1697–1708CrossRefPubMed Starup-Linde J, Eriksen SA, Lykkeboe S, Handberg A, Vestergaard P (2014) Biochemical markers of bone turnover in diabetes patients—a meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos Int 25:1697–1708CrossRefPubMed
32.
go back to reference Starup-Linde J, Vestergaard P (2016) Biochemical bone turnover markers in diabetes mellitus—a systematic review. Bone 82:69–78CrossRefPubMed Starup-Linde J, Vestergaard P (2016) Biochemical bone turnover markers in diabetes mellitus—a systematic review. Bone 82:69–78CrossRefPubMed
33.
go back to reference Yamamoto M, Yamauchi M, Sugimoto T (2013) Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 98:4030–4037CrossRefPubMed Yamamoto M, Yamauchi M, Sugimoto T (2013) Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 98:4030–4037CrossRefPubMed
34.
go back to reference De Laet C, Kanis JA, Odén A et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16(11):1330–1338CrossRef De Laet C, Kanis JA, Odén A et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16(11):1330–1338CrossRef
35.
go back to reference Department of Disease Control Ministry of Health, PR China (2006) Guidelines for prevention and control of overweight and obesity in Chinese adults. People’s Medical Publishing House, Beijing Department of Disease Control Ministry of Health, PR China (2006) Guidelines for prevention and control of overweight and obesity in Chinese adults. People’s Medical Publishing House, Beijing
36.
go back to reference Zhao J, Xia W, Nie M et al (2011) The levels of bone turnover markers in Chinese postmenopausal women: peking Vertebral Fracture study. Menopause 18(11):1237–1243CrossRefPubMed Zhao J, Xia W, Nie M et al (2011) The levels of bone turnover markers in Chinese postmenopausal women: peking Vertebral Fracture study. Menopause 18(11):1237–1243CrossRefPubMed
37.
go back to reference Zhao J, Xia W, Nie M et al (2012) A haplotype of MATN3 is associated with vertebral fracture in Chinese postmenopausal women: peking Vertebral Fracture (PK-VF) study. Bone 50(4):917–924CrossRefPubMedPubMedCentral Zhao J, Xia W, Nie M et al (2012) A haplotype of MATN3 is associated with vertebral fracture in Chinese postmenopausal women: peking Vertebral Fracture (PK-VF) study. Bone 50(4):917–924CrossRefPubMedPubMedCentral
38.
go back to reference Zhang ZHSJX, Shen JX (2005) Liu ZH (2005) Retrospective study on standardization of BMD machines in China. Chin J Osteoporos 11(2):133–145 Zhang ZHSJX, Shen JX (2005) Liu ZH (2005) Retrospective study on standardization of BMD machines in China. Chin J Osteoporos 11(2):133–145
39.
go back to reference Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8(9):1137–1148CrossRefPubMed Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8(9):1137–1148CrossRefPubMed
40.
go back to reference Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, Womack CR, Palermo L, Black DM (2011) Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305:2184–2192CrossRefPubMedPubMedCentral Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, Womack CR, Palermo L, Black DM (2011) Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305:2184–2192CrossRefPubMedPubMedCentral
41.
go back to reference Christiansen BA, Kopperdahl DL, Kiel DP, Keaveny TM, Bouxsein ML (2011) Mechanical contributions of the cortical and trabecular compartments contribute to differences in age-related changes in vertebral body strength in men and women assessed by QCT-based finite element analysis. J Bone Miner Res 26(5):974–983CrossRefPubMedPubMedCentral Christiansen BA, Kopperdahl DL, Kiel DP, Keaveny TM, Bouxsein ML (2011) Mechanical contributions of the cortical and trabecular compartments contribute to differences in age-related changes in vertebral body strength in men and women assessed by QCT-based finite element analysis. J Bone Miner Res 26(5):974–983CrossRefPubMedPubMedCentral
42.
go back to reference Burghardt AJ, Issever AS, Schwartz AV et al (2010) High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95(11):5045–5055CrossRefPubMedPubMedCentral Burghardt AJ, Issever AS, Schwartz AV et al (2010) High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95(11):5045–5055CrossRefPubMedPubMedCentral
43.
go back to reference Oei L, Zillikens MC, Dehghan A et al (2013) High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care 36(6):1619–1628CrossRefPubMedPubMedCentral Oei L, Zillikens MC, Dehghan A et al (2013) High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care 36(6):1619–1628CrossRefPubMedPubMedCentral
44.
go back to reference Patsch JM, Burghardt AJ, Yap SP et al (2013) Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. J Bone Miner Res 28(2):313–324CrossRefPubMedPubMedCentral Patsch JM, Burghardt AJ, Yap SP et al (2013) Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. J Bone Miner Res 28(2):313–324CrossRefPubMedPubMedCentral
45.
go back to reference Kurra S, Siris E (2011) Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures. Diabetes Metab Res Rev 27(5):430–435CrossRefPubMed Kurra S, Siris E (2011) Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures. Diabetes Metab Res Rev 27(5):430–435CrossRefPubMed
46.
go back to reference Cundy TF, Edmonds ME, Watkins PJ (1985) Osteopenia and metatarsal fractures in diabetic neuropathy. Diabetes Med 2(6):461–464CrossRef Cundy TF, Edmonds ME, Watkins PJ (1985) Osteopenia and metatarsal fractures in diabetic neuropathy. Diabetes Med 2(6):461–464CrossRef
47.
go back to reference Kathol MH, el-Khoury GY, Moore TE, Marsh JL (1991) Calcaneal insufficiency avulsion fractures in patients with diabetes mellitus. Radiology 180(3):725–729CrossRefPubMed Kathol MH, el-Khoury GY, Moore TE, Marsh JL (1991) Calcaneal insufficiency avulsion fractures in patients with diabetes mellitus. Radiology 180(3):725–729CrossRefPubMed
Metadata
Title
Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study
Authors
Ruizhi Jiajue
Xuan Qi
Yan Jiang
Qiuping Wang
Wenbo Wang
Yu Pei
Xiran Wang
Wei Huang
Xin Zheng
Zhiwei Ning
Ou Wang
Mei Li
Xiaoping Xing
Wei Yu
Ling Xu
Weibo Xia
Publication date
01-11-2019
Publisher
Springer US
Published in
Calcified Tissue International / Issue 5/2019
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-019-00598-x

Other articles of this Issue 5/2019

Calcified Tissue International 5/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine